Prognostic value of p53, hMLH1, hMSH2, MGMT and COX-2 in the QUASAR-1 Dukes' stage B colorectal cancer cohort
Hauptverfasser: | Jubb, A, Stahlschmidt, J, Bell, S, Gray, S, Harkins, L, Scott, N, McConkey, C, Grummett, S, Barnwell, J, Seymour, M, Gray, R, Kerr, D, Quirke, P, Grp, Q |
---|---|
Format: | Journal article |
Veröffentlicht: |
2002
|
Ähnliche Einträge
-
Aberrantly Methylated MGMT, hMLH1 and hMSH2 in Tumor and Serum DNA of Gliomas Patients
von: Chanqing ZHENG, et al.
Veröffentlicht: (2009-02-01) -
Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer.
von: Dandan Li, et al.
Veröffentlicht: (2013-01-01) -
Link between immunoexpression of hMLH1 and hMSH2 proteins and clinical-epidemiological aspects of actinic cheilitis
von: Dmitry José de Santana Sarmento, et al.
Veröffentlicht: (2016-08-01) -
Allele loss occurs frequently at hMLH1, but rarely at hMSH2, in sporadic colorectal cancers with microsatellite instability.
von: Tomlinson, I, et al.
Veröffentlicht: (1996) -
Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.
von: Catto, J, et al.
Veröffentlicht: (2003)